Skinvisible Q2 FY26 net loss narrows to USD 255,533; revenue flat at USD 5,000
Reuters2026/08/13 18:42- Skinvisible posted a net loss of USD 255,533 for Q2 2026, narrowing from a loss of USD 274,427 a year earlier.
- Revenue held flat at USD 5,000 versus the prior-year quarter, while operating expenses fell to USD 117,817 from USD 141,237.
- Interest expense drove other expenses of USD 142,716, little changed from USD 142,720 in the year-ago quarter.
- Working capital deficit widened to USD 5.5 million at June 30, 2026, from USD 4.99 million at Dec. 31, 2025.
- Quoin’s QRX003 remains on track for Phase 3 recruitment completion by end-2026, with a potential FDA filing targeted for 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Oman becomes the "middle layer"! Trump threatens military strike if Oman obstructs U.S.-Iran conflict
According to reports, U.S. President Donald Trump issued a stern warning in a telephone interview, stating that if Oman obstructs U.S. military forces during the blockade of Iranian vessels in the Strait of Hormuz, the United States will take military action against Oman.
WASGAU opens first Baden-Wuerttemberg fresh market in Mannheim
UPM-Kymmene calls extraordinary shareholder meeting
Claritev says Marpai expands contract for pre- and post-payment claims integrity services
Crypto prices
More
